CONGENITAL BONE MARROW FAILURE SYNDROMES
Clinical trials for CONGENITAL BONE MARROW FAILURE SYNDROMES explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL BONE MARROW FAILURE SYNDROMES trials appear
Sign up with your email to follow new studies for CONGENITAL BONE MARROW FAILURE SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Milder chemo before stem cell transplant shows promise for rare blood disorders
Disease control Recruiting nowThis study tracks 50 children and adults with non-malignant disorders like immune deficiencies and anemias who receive a stem cell transplant after a reduced-intensity chemotherapy regimen. The goal is to see if this approach improves survival and reduces severe graft-versus-host…
Matched conditions: CONGENITAL BONE MARROW FAILURE SYNDROMES
Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Milder transplant method aims to help young patients with rare blood diseases
Disease control Recruiting nowThis study is testing a less intense chemotherapy and radiation regimen before a stem cell transplant for children and young adults up to age 55 with non-cancerous blood disorders like immune deficiencies, anemias, and metabolic diseases. The goal is to see if this gentler prepar…
Matched conditions: CONGENITAL BONE MARROW FAILURE SYNDROMES
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC